Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
05/2003
05/30/2003WO2002016313A3 Integrin receptor inhibitors
05/30/2003CA2467910A1 Modulators of rho c activity
05/30/2003CA2467798A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
05/30/2003CA2467476A1 Amino diols useful in the treatment of alzheimer's disease
05/30/2003CA2466916A1 New use for the treatment of gastroesophageal reflux disease
05/30/2003CA2464314A1 Pyrrole synthesis
05/29/2003US20030100757 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives interacting with the dopamine D4 receptor
05/29/2003US20030100681 Crosslinkable monomers for novel nonlinear optical polymers
05/29/2003US20030100599 2-amino-fluorene derivatives useful for prophylactic and/or therapeutic treatment of diseases and conditions associated with alpha 4 intergrins or their ligands
05/29/2003US20030100596 Arylsulphonyl substituted-tetrahydro- and hexahydro-carbazoles
05/29/2003US20030100588 Indole-type inhibitors of p38 kinase
05/29/2003US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
05/29/2003US20030100545 Psychological disorder treatments that increase the activity of cholinergic receptors
05/28/2003EP1314733A1 Indole-2-carboxamides as factor Xa inhibitors
05/28/2003EP1313719A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
05/28/2003EP1313696A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
05/28/2003EP1313694A1 Process for making n-aryl-anthranilic acids and their derivatives
05/28/2003EP1313477A1 Compounds and methods
05/28/2003EP1313468A2 Pharmaceutical combination of angiotensin ii antagonists and ace inhibitors
05/28/2003EP1117627B1 Transfer hydrogenation process
05/28/2003EP0973763B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
05/28/2003CN1420889A Pharmaceutically active isoindoline derivs.
05/28/2003CN1420880A Substd. N-Benzyl-indol-3-yl glyoxylic acid derivs. having anti-tumoral effect
05/28/2003CN1420872A Caspase inhibitors and use thereof
05/28/2003CN1420868A Process for preparation of benzamide deriv. of formula (1) and its salts
05/28/2003CN1420867A Method for synthesis of perindopril and its pharmaceutically acceptable salts
05/28/2003CN1420862A Method for synthesis of N-ÒÇö(S)-1-carboxybutylÒÇò-(S)- alanine esters and use in synthesis of perindopril
05/28/2003CN1420111A Naphthalene alizarin derivatives, preparing method and use thereof
05/28/2003CN1109499C Fungicide active substance combinations
05/27/2003US6570023 Process for preparing toluenesulfinates
05/27/2003US6569978 4-(9-carbazolylmethyl)styrene monomer; homo- and co-polymers; heat resistance, optical properties, and narrow molecular weight distribution
05/27/2003US6569896 Useful for oral testosterone replacement therapy, male contraception, maintaining sexual desire in women, treating prostate cancer and imaging prostate cancer
05/27/2003US6569888 Such as ethyl-N-(dichlorobenzyl)-4-(3-hydroxypropylthio) indole-2-carboxylate; for treatment of arthritis
05/27/2003US6569887 (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
05/27/2003US6569868 Imidazoly 2-indolinones as anticarcinogenic, -diabetic, -arthritic, -proliferative and inflammatory agents; fibrosis; autoimmune disorder, angiogenesis, restenosis, psoriasis, osteoarthritis and rheumatoid arthritis
05/27/2003US6569858 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo[3,4-c]carbazole and 12,13-(pyranosyl)-furo[3,4-c]indolo[2,3-a]carbazoles
05/27/2003CA2213054C Novel bis(imido) derivatives, a process for their preparation and pharmaceutical compositions containing them
05/22/2003WO2003042184A1 Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control
05/22/2003WO2003042176A1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation
05/22/2003WO2003042175A1 Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
05/22/2003WO2003042153A1 Difluoroalkene derivative and pest control agent containing the same
05/22/2003WO2003022280A3 3-glyoxlylamideindoles for treating cancer
05/22/2003WO2003018004A3 Analgetic pyrroline derivatives
05/22/2003WO2003006670A3 2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
05/22/2003WO2002059165A3 Polymerization of olefinic compounds
05/22/2003WO2002044168A3 Indole-type inhibitors of p38 kinase
05/22/2003US20030096858 The parent drug compound is modified by forming one or more of predetermined chemical arrangement within parent drug structure for programming specific course and rate of metabolism for drug that leads to inactive nontoxic metabolite
05/22/2003US20030096856 Compounds such as N-((dimethylamino)acetyl)-1-methyl-N-(3, 4,5-trimethoxyphenyl)-1H-indole-5-sulfonamide for therapy of cancer
05/22/2003US20030096854 Substituted tricyclics
05/22/2003US20030096825 Antiviral activity; treatment of HIV and AIDS
05/22/2003US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/22/2003US20030096806 For use as pesicides, herbicides; crop protection
05/22/2003US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders
05/22/2003US20030096379 Method for producing tryptamine derivatives
05/22/2003US20030096374 Synthesis of oligoketides
05/22/2003US20030095992 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots
05/22/2003CA2466971A1 Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control
05/21/2003EP1312601A1 Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
05/21/2003EP1311478A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
05/21/2003EP1311477A1 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same
05/21/2003EP1311475A1 Novel aminocyclohexane derivatives
05/21/2003EP1311293A2 Combinations of ssri and estrogenic agents
05/21/2003EP1311263A2 Fused pyrrolocarbazoles against inflammation
05/21/2003EP1311255A1 Compounds having mif antagonist activity
05/21/2003EP0964863B1 Oxazolidines as 5-ht2a-antagonists
05/21/2003EP0874818B1 Novel substituted aryl compounds useful as modulators of acetylcholine receptors
05/21/2003EP0851855B9 Acylated derivatives of melatonin and its analogues, useful as medicaments
05/21/2003CN1419466A Sublimation purifying method and apparatus
05/21/2003CN1418872A 1,4-pentadiene-3-ketone compound containing halogenoindyl, and method for preparing same and medicinal use thereof
05/20/2003US6567204 Electrochromic solution containing hydrazone compound and device manufactured with same
05/20/2003US6566533 Reacting aza-heterocyclic compounds (indoles and carbazoles) with alkyl- or aryl-halides in the presence of carbon dioxide and alkali carbonate
05/20/2003US6566372 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer
05/20/2003US6566364 Linear or cyclic ureas
05/20/2003US6566071 Useful as fluorescent labeling reagents
05/20/2003US6565997 Superior in vibration transmittability between ceramic substrate and piezoelectric
05/20/2003US6565829 Psychological disorders; central nervous system disorders
05/20/2003CA2281244C Process for preparing trovafloxacin acid salts
05/20/2003CA2234239C Indole carbamates as leukotriene antagonists
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/20/2003CA2099994C Phenyl amidines derivatives useful as platelet aggregation inhibitors
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003007071A3 Novel nonlinear optical compounds and polymers
05/15/2003WO2002058679A3 Antiangiogenic compounds and an assay for inhibitors of cell invasion
05/15/2003US20030092869 Crosslinking; heat resistance, stability
05/15/2003US20030092756 Antiproliferative agents
05/15/2003US20030092751 3-glyoxlylamideindoles for treating cancer
05/15/2003US20030092728 Antagonists of MCP-1 function and methods of use thereof
05/15/2003US20030092717 Inhibitors of p38 kinase
05/15/2003US20030092715 Aryl and biaryl compounds having MCH modulatory activity
05/15/2003US20030092703 Caspase inhibitors and uses thereof
05/15/2003US20030092140 Novel polyketides and antibiotics
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/14/2003EP1310489A1 Electrophotographic organophotoreceptor with charge transport compounds
05/14/2003EP1310488A1 Fused bicyclic amide compounds and medicinal use thereof
05/14/2003EP1310487A1 Processes for preparation of bicyclic compounds and intermediates therefor
05/14/2003EP1310486A1 Process for producing 5-fluorooxyindole and for producing intermediate therefor
05/14/2003EP1310482A1 Prodrugs of excitatory amino acids
05/14/2003EP1309586A1 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders
05/14/2003EP1309577A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
05/14/2003EP1309552A1 Compounds and inhibitors of phospholipases